HIV-1 clade C infection and progressive disruption in the relationship between cortisol, DHEAS and CD4 cell numbers: A two-year follow-up study

Clinica Chimica Acta

Volumn 409, Issue 1-2, 2009, Pages 4-10

  Chittiprol, Seetharamaiah ^a,d   Kumar, Adarsh M ^c   Shetty, K Taranath ^a   Ravi Kumar, H ^a   Satishchandra, P ^a   Rao, R S Bhimasena ^a   Ravi, V ^a   Desai, A ^a   Subbakrishna, D K ^a   Philip, Mariamma ^a   Satish, K S ^b   Kumar, Mahendra ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b Seva Clinic   (India)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Body mass index (BMI); CD4 cell count; CD4:CD8 ratio; Clade C; Cortisol; Cortisol:DHEAS (C D) ratio; DHEAS; HAART; HIV 1

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HYDROCORTISONE; PRASTERONE SULFATE;

ADRENAL CORTEX DISEASE; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYDROCORTISONE BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DEHYDROEPIANDROSTERONE SULFATE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NEUROSECRETORY SYSTEMS; SEX CHARACTERISTICS; YOUNG ADULT;

CERCOPITHECINE HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70249100355     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.06.032     Document Type: Article

References (48)

1. Clerici M., and Shearer G.M. A TH1ÄTH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14 (1993) 107-111
2. Clerici M., and Shearer G.M. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 15 (1994) 575-581
3. Aron D.C. Endocrine complications of the acquired immunodeficiency syndrome. Arch Intern Med 149 (1989) 330-333
4. Chittiprol S., Shetty K.T., Kumar A.M., et al. HPA axis activity and neuropathogenesis in HIV-1 clade C infection. Front Biosci 12 (2007) 1271-1277
5. Glasgow B.J., Steinsapir K.D., Anders K., and Layfield L.J. Adrenal pathology in the acquired immune deficiency syndrome. Am J Clin Pathol 84 (1985) 594-597
6. Kumar M., Kumar A.M., Waldrop D., Antoni M.H., Schneiderman N., and Eisdorfer C. The HPA axis in HIV-1 infection. J Acquir Immune Defic Syndr 31 Suppl 2 (2002) S89-S93
7. Antoni M.H. Stress management and psychoneuroimmunology in HIV infection. CNS Spectr 8 (2003) 40-51
8. Clerici M., Sarin A., Coffman R.L., et al. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA 91 (1994) 11811-11815
9. Chesnokova V., and Melmed S. Minireview: neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 143 (2002) 1571-1574
10. Besedovsky H.O., and del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17 (1996) 64-102
11. Grinspoon S.K., and Bilezikian J.P. HIV disease and the endocrine system. N Engl J Med 327 (1992) 1360-1365
12. Hofbauer L.C., and Heufelder A.E. Endocrine implications of human immunodeficiency virus infection. Medicine (Baltimore) 75 (1996) 262-278
13. Kumar M., Kumar A.M., Morgan R., Szapocznik J., and Eisdorfer C. Abnormal pituitary-adrenocortical response in early HIV-1 infection. J Acquir Immune Defic Syndr 6 (1993) 61-65
14. Kumar M., Goodkin K., Kumar A.M., Baldewiez T.T., Morgan R., and Eisdorfer C. HIV -1 Infection, neuroendocrine abnormalities and clinical outcomes. CNS Spectrums 5 (2000) 55-65
15. Kumar M., Kumar A.M., Waldrop D., Antoni M.H., and Eisdorfer C. HIV-1 infection and its impact on the HPA axis, cytokines, and cognition. Stress 6 (2003) 167-172
16. Chittiprol S., Kumar A.M., Satishchandra P., et al. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India. Psychoneuroendocrinology 33 (2008) 30-40
17. Chittiprol S., Shetty K.T., Kumar A.M., et al. Correlation of neuroendocrine parameters to virological and immunological findings in HIV-1 clade C infection. J Neurochem 94 Supplement 2 (2005) 253
18. Membreno L., Irony I., Dere W., Klein R., Biglieri E.G., and Cobb E. Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 65 (1987) 482-487
19. Clerici M., Trabattoni D., Piconi S., et al. A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus. Psychoneuroendocrinology 22 Suppl 1 (1997) S27-S31
20. Clerici M., Galli M., Bosis S., Gervasoni C., Moroni M., and Norbiato G. Immunoendocrinologic abnormalities in human immunodeficiency virus infection. Ann NY Acad Sci 917 (2000) 956-961
21. Khalsa J.H., Vocci F., and Dobs A. Hormonal and metabolic disorders of human immunodeficiency virus infection and substance abuse. Am J Infect Dis 2 (2006) 125-129
22. Dobs A., and Brown T. Metabolic abnormalities in HIV disease and injection drug use. J Acquir Immune Defic Syndr 31 Suppl 2 (2002) S70-S77
23. Cruess D.G., Antoni M.H., Kumar M., et al. Cognitive-behavioral stress management buffers decreases in dehydroepiandrosterone sulfate (DHEA-S) and increases in the cortisol/DHEA-S ratio and reduces mood disturbance and perceived stress among HIV-seropositive men. Psychoneuroendocrinology 24 (1999) 537-549
24. Carrico A.W., and Antoni M.H. Effects of psychological interventions on neuroendocrine hormone regulation and immune status in HIV-positive persons: a review of randomized controlled trials. Psychosom Med 70 (2008) 575-584
25. Blalock J.E., Harbour-McMenamin D., and Smith E.M. Peptide hormones shared by the neuroendocrine and immunologic systems. J Immunol 135 (1985) 858s-861s
26. Blalock J.E. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev 69 (1989) 1-32
27. Blalock J.E. The syntax of immune-neuroendocrine communication. Immunol Today 15 (1994) 504-511
28. Claman H.N. Glucocorticosteroids I: anti-inflammatory mechanisms. Hosp Pract (Off Ed) 18 (1983) 123-124
29. Fauci A.S., Dale D.C., and Balow J.E. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 84 (1976) 304-315
30. Bradlow H.L., Murphy J., and Byrne J.J. Immunological properties of dehydroepiandrosterone, its conjugates, and metabolites. Ann NY Acad Sci 876 (1999) 91-101
31. Jacobson M.A., Fusaro R.E., Galmarini M., and Lang W. Decreased serum dehydroepiandrosterone is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200-499. J Infect Dis 164 (1991) 864-868
32. Mulder J.W., Frissen P.H., Krijnen P., et al. Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men. J Infect Dis 165 (1992) 413-418
33. Suitters A.J., Shaw S., Wales M.R., et al. Immune enhancing effects of dehydroepiandrosterone and dehydroepiandrosterone sulphate and the role of steroid sulphatase. Immunology 91 (1997) 314-321
34. Wisniewski T.L., Hilton C.W., Morse E.V., and Svec F. The relationship of serum DHEA-S and cortisol levels to measures of immune function in human immunodeficiency virus-related illness. Am J Med Sci 305 (1993) 79-83
35. Davis S.R., Shah S.M., McKenzie D.P., Kulkarni J., Davison S.L., and Bell R.J. Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women. J Clin Endocrinol Metab 93 (2008) 801-808
36. Haren M.T., Malmstrom T.K., Banks W.A., Patrick P., Miller D.K., and Morley J.E. Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women. Maturitas 57 (2007) 347-360
37. Nishimura T., Seki Y., Sato K., et al. Enhancement of zidovudine uptake by dehydroepiandrosterone sulfate in rat syncytiotrophoblast cell line TR-TBT 18d-1. Drug Metab Dispos 36 (2008) 2080-2085
38. Poretsky L., Brillon D.J., Ferrando S., et al. Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial. Metabolism 55 (2006) 858-870
39. Swanson B., Zeller J.M., and Spear G.T. Cortisol upregulates HIV p24 antigen production in cultured human monocyte-derived macrophages. J Assoc Nurses AIDS Care 9 (1998) 78-83
40. Vago T., Clerici M., and Norbiato G. Glucocorticoids and the immune system in AIDS. Baillieres Clin Endocrinol Metab 8 (1994) 789-802
41. Kandathil A.J., Kannangai R., David S., et al. Human immunodeficiency virus infection and levels of dehydroepiandrosterone sulfate in plasma among Indians. Clin Diagn Lab Immunol 12 (2005) 1117-1118
42. Gronowski A.M., and Landau-Levine M. Reproductive endocrine function. In: Burtis C.A., and Ashwood E.R. (Eds). Tietz fundamentals of clinical chemistry. 5th ed (2003), Saunders, Philadelphia 876-897
43. Bavry A.A., Mood G.R., Kumbhani D.J., Borek P.P., Askari A.T., and Bhatt D.L. Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials. Am J Cardiovasc Drugs 7 (2007) 135-141
44. Wenxue L.i., Huang Y., Reid R., et al. NMDA receptor activation by HIV-Tat protein is clade dependent. J Neurosci 28 47 (2008) 12190-12198
45. Parker L.N., Levin E.R., and Lifrak E.T. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 60 (1985) 947-952
46. Zumoff B., Walsh B.T., Katz J.L., et al. Subnormal plasma dehydroisoandrosterone to cortisol ratio in anorexia nervosa: a second hormonal parameter of ontogenic regression. J Clin Endocrino Metab 56 (1983) 668-672
47. Christeff N., Nunez E.A., and Gougeon M.L. Changes in cortisol/DHEA ratio in HIV-1 infected men are related to immunological and metabolic perturbations leading to malnutrition and lipodystrophy. Ann NY Acad of Sci 917 (2000) 962-970
48. Chittiprol S. Lipid metabolism. In: Chittiprol S. (Ed). Biochemistry: instant notes for medical students. 1st ed (2006), Jaypee Medical Publishers (P) Ltd, New Delhi 152-185